Preclinical evaluation of an immunotherapeutic peptide comprising 7 T-cell determinants of Cry j 1 and Cry j 2, the major Japanese cedar pollen allergens

Journal of Allergy and Clinical Immunology

Volumn 108, Issue 1, 2001, Pages 94-100

  Hirahara, Kazuki ^a   Tatsuta, Toru ^a   Takatori, Toshiro ^a   Ohtsuki, Masahiko ^a   Kirinaka, Hideyo ^a   Kawaguchi, Junko ^a   Serizawa, Nobufusa ^a   Taniguchi, Yoshifumi ^b   Saito, Saburo ^c   Sakaguchi, Masahiro ^d   Inouye, Sakae ^d   Shiraishi, Akio ^a  

^a DAIICHI SANKYO CO   (Japan)

^b HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Allergen; Cry j 1; Cry j 2; Epitope; IgE; Immunotherapy; Japanese cedar pollen; Peptide; T cell determinant

Indexed keywords

ANTIGEN CRY J 1; ANTIGEN CRY J 2; HYBRID PROTEIN; IMMUNOGLOBULIN E ANTIBODY; POLLEN ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ANTIGEN BINDING; ARTICLE; ASSAY; CEDAR; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; FEMALE; HUMAN; IMMUNOTHERAPY; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; POLLEN ALLERGY; PRIORITY JOURNAL; T LYMPHOCYTE; TREE;

EID: 0034919459     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2001.115481     Document Type: Article

References (22)

1. Allergen immunotherapy: Therapeutic vaccines for allergic diseases. A WHO position paper
2. Immunologic changes associated with allergen immunotherapy
3. Immunological mechanism operative in allergen-specific immunotherapy
4. Peptide immunotherapy
5. Peptide-mediated immune responses in specific immunotherapy
6. Integrated clinical experience with tolerogenic peptides
7. Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats
8. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom
9. Immunological activity of covalently linked T-cell epitopes
10. Potential therapeutic recombinant proteins comprised of peptides containing recombined T cell epitopes
11. T cell epitopes in Japanese cedar (Cryptomeria japonica) pollen allergens: Choice of major T cell epitopes in Cry j 1 and Cry j 2 toward design of the peptide-based immunotherapeutics for the management of Japanese cedar pollinosis
12. Isolation and partial characterization of the major allergen from Japanese cedar (Cryptomeria japonica) pollen
13. Identification of the second major allergen of Japanese cedar pollen
14. Sensitivity to two major allergens (Cry j I and Cry j II) in patients with Japanese cedar (Cryptomeria japonica) pollinosis
15. Th1/Th2 response profiles to the major allergens Cry j 1 and Cry j 2 of Japanese cedar pollen
16. Identification of T cell determinants in Cry j 1 and Cry j 2 of size suitable for immunotherapy against Japanese cedar pollinosis
17. Fluorometric enzyme-linked immunosorbent assay for the measurement of IgE antibody to Cryptomeria japonica pollen
18. H2 cell responses in Cry j 2-primed mice
19. Human T cell response to antigen peptides of Japanese cedar pollen (Cry j 1)
20. Immunodominance of seven regions of a major allergen, Cry j 2, of Japanese cedar pollen for T-cell immunity
21. Induction and suppression of an autoimmune disease by oligomerized T cell epitopes: Enhanced in vivo potency of encephalitogenic peptides
22. Identification of a sequential B-cell epitope on major allergen (Cry j 1) of Japanese cedar (Cryptomeria japonica) pollen in mice